TissGeneSummary for GYPA |
Gene summary |
Basic gene information | Gene symbol | GYPA |
Gene name | glycophorin A (MNS blood group) | |
Synonyms | CD235a|GPA|GPErik|GPSAT|HGpMiV|HGpMiXI|HGpSta(C)|MN|MNS|PAS-2 | |
Cytomap | UCSC genome browser: 4q31.21 | |
Type of gene | protein-coding | |
RefGenes | NM_002099.6, | |
Description | MN sialoglycoproteinMi.V glycoprotein (24 AA)erythroid-lineage-specific membrane sialoglycoproteinglycophorin A (MN blood group)glycophorin A, GPAglycophorin Erikglycophorin MiIglycophorin MiVglycophorin SATglycophorin Sta type Cglycophorin-Are | |
Modification date | 20141207 | |
dbXrefs | MIM : 111300 | |
HGNC : HGNC | ||
Ensembl : ENSG00000170180 | ||
HPRD : 07508 | ||
Vega : OTTHUMG00000161403 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_GYPA | |
BioGPS: 2993 | ||
Pathway | NCI Pathway Interaction Database: GYPA | |
KEGG: GYPA | ||
REACTOME: GYPA | ||
Pathway Commons: GYPA | ||
Context | iHOP: GYPA | |
ligand binding site mutation search in PubMed: GYPA | ||
UCL Cancer Institute: GYPA | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,TiGER | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Bone marrow | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LAML | |
Reference showing the relevant tissue of GYPA | ||
Description by TissGene annotations | TissgsKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for GYPA |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | -0.310616794 | 2.504727206 | -2.815344 | 2.36E-06 | 8.31E-06 |
KIRP | 0.911629331 | 3.444041831 | -2.5324125 | 3.30E-06 | 1.50E-05 |
KIRC | 1.845844261 | 2.91487065 | -1.069026389 | 0.0018 | 0.003309106 |
Top |
TissGene-miRNA for GYPA |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for GYPA |
TissGeneSNV for GYPA |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.R115C | SKCM | 2 |
p.H85L | LIHC | 2 |
p.G78E | SKCM | 2 |
p.Y53H | LUAD | 1 |
p.A26V | COAD | 1 |
p.G98E | SKCM | 1 |
p.R80S | LUAD | 1 |
p.E141K | BLCA | 1 |
p.I106N | STAD | 1 |
p.D134V | LIHC | 1 |
p.P145Q | SKCM | 1 |
p.I99L | STAD | 1 |
p.P129S | SKCM | 1 |
p.E89Q | BLCA | 1 |
p.S111F | SKCM | 1 |
p.L128V | BLCA | 1 |
p.E141K | HNSC | 1 |
p.E141* | BLCA | 1 |
p.A54E | COAD | 1 |
p.E61K | SKCM | 1 |
p.R115C | GBM | 1 |
p.P72S | SKCM | 1 |
p.A84D | ESCA | 1 |
p.T47M | HNSC | 1 |
p.E61X | COAD | 1 |
p.T147K | HNSC | 1 |
p.E89K | SKCM | 1 |
p.T93P | STAD | 1 |
p.P131H | HNSC | 1 |
p.D149N | UCEC | 1 |
p.R116Q | READ | 1 |
p.H85L | LUAD | 1 |
p.E143K | SKCM | 1 |
p.A84V | HNSC | 1 |
Top |
TissGeneCNV for GYPA |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for GYPA |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | LUSC | TCGA-77-7142-11A | SAV1-GYPA | In-Frame | chr14:51131896 | chr4:145041741 |
Top |
TissGeneNet for GYPA |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for GYPA |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for GYPA |
TissGeneDrug for GYPA |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for GYPA |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0024530 | Malaria | 5 | BeFree,CTD_human,GAD |
umls:C0015625 | Fanconi Anemia | 3 | BeFree |
umls:C0020538 | Hypertensive disease | 3 | BeFree,GAD |
umls:C0023418 | leukemia | 3 | BeFree |
umls:C0023440 | Acute Erythroblastic Leukemia | 3 | BeFree |
umls:C0024117 | Chronic Obstructive Airway Disease | 3 | GAD |
umls:C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 3 | BeFree |
umls:C0001973 | Alcoholic Intoxication, Chronic | 2 | BeFree |
umls:C0004096 | Asthma | 2 | GAD |
umls:C0004135 | Ataxia Telangiectasia | 2 | BeFree |
umls:C0010346 | Crohn Disease | 2 | GAD |
umls:C0037889 | Hereditary spherocytosis | 2 | BeFree |
umls:C0042384 | Vasculitis | 2 | BeFree |
umls:C0343192 | Microscopic Polyangiitis | 2 | BeFree |
umls:C0596263 | Carcinogenesis | 2 | BeFree |
umls:C2674218 | SPHEROCYTOSIS, TYPE 1 (disorder) | 2 | BeFree |
umls:C0002874 | Aplastic Anemia | 1 | BeFree |
umls:C0002875 | Cooley's anemia | 1 | BeFree |
umls:C0006277 | Bronchitis | 1 | BeFree |
umls:C0008677 | Bronchitis, Chronic | 1 | BeFree |
umls:C0008728 | Churg-Strauss Syndrome | 1 | BeFree |
umls:C0009207 | Cockayne Syndrome | 1 | BeFree |
umls:C0011570 | Mental Depression | 1 | BeFree |
umls:C0011581 | Depressive disorder | 1 | BeFree |
umls:C0014761 | Erythroblastosis, Fetal | 1 | BeFree |
umls:C0018213 | Graves Disease | 1 | BeFree |
umls:C0019045 | Hemoglobinopathies | 1 | BeFree |
umls:C0023449 | Acute lymphocytic leukemia | 1 | BeFree |
umls:C0023467 | Leukemia, Myelocytic, Acute | 1 | BeFree |
umls:C0024591 | Malignant hyperpyrexia due to anesthesia | 1 | BeFree |
umls:C0024790 | Paroxysmal nocturnal hemoglobinuria | 1 | BeFree |
umls:C0026691 | Mucocutaneous Lymph Node Syndrome | 1 | GAD |
umls:C0027051 | Myocardial Infarction | 1 | GAD |
umls:C0032461 | Polycythemia | 1 | LHGDN |
umls:C0032463 | Polycythemia Vera | 1 | BeFree |
umls:C0034152 | Henoch-Schoenlein Purpura | 1 | GAD |
umls:C0037286 | Skin Neoplasms | 1 | BeFree,CTD_human |
umls:C0043119 | Werner Syndrome | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
umls:C0263361 | Psoriasis vulgaris | 1 | GAD |
umls:C0265962 | Ichthyosis linearis circumflexa | 1 | BeFree |
umls:C0268225 | Aspartylglucosaminuria | 1 | BeFree |
umls:C0280100 | Solid tumour | 1 | BeFree |
umls:C0349653 | Congenital disorder of glycosylation type 1A | 1 | BeFree |
umls:C0392707 | Atopy | 1 | GAD |
umls:C0684249 | Carcinoma of lung | 1 | BeFree |
umls:C1327915 | Congenital amegakaryocytic thrombocytopenia | 1 | BeFree |
umls:C1704380 | Distal Renal Tubular Acidosis | 1 | BeFree |
umls:C1856689 | FRIEDREICH ATAXIA 1 | 1 | BeFree |
umls:C1862839 | Anterior segment mesenchymal dysgenesis | 1 | BeFree |
umls:C2678503 | AXENFELD-RIEGER SYNDROME, TYPE 3 | 1 | BeFree |
umls:C2717865 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | BeFree |
umls:C2939465 | Deficiency of glucose-6-phosphate dehydrogenase | 1 | BeFree |
umls:C3550904 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is | 1 | BeFree |